Orchid in deal with Stada for generic drug products
17 Mar 2005
New Delhi: Indian drugmaker Orchid Chemicals and Pharmaceuticals Ltd has inked a deal with Germany's STADA Arzneimittel AG for the development and supply of six prescription generic drug products to STADA for the American market.
The six drugs include those for the heart, the central nervous system, the gastrointestinal system, allergies and infection.
Orchid hopes to supply the drugs to STADA by the beginning of 2007 when the patents of the original products expire in the US.